This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of North Carolina at Chapel Hill. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Deyu Kong: Innovator in Aryl Aminopyrimidines
Introduction
Deyu Kong is a prominent inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific kinase activities. His work is crucial in the fight against various diseases, including cancer.
Latest Patents
Deyu Kong holds a patent for "Aryl aminopyrimidines as dual MerTK and TYRO3 inhibitors and methods thereof." This patent describes aminopyrimidine-containing compounds that inhibit both Mer tyrosine kinase (MerTK) activity and Tyro3 kinase activity. The patent also outlines methods of synthesis and the use of these compounds as anti-cancer agents, immunostimulatory and immunomodulatory agents, anti-platelet agents, and anti-infective agents. He has 1 patent to his name.
Career Highlights
Deyu Kong is affiliated with the University of North Carolina at Chapel Hill, where he conducts his research. His work has garnered attention for its potential applications in therapeutic settings, particularly in oncology and immunology.
Collaborations
Deyu Kong has collaborated with notable colleagues, including Xiaodong Wang and Yubai Zhou. Their combined expertise enhances the research output and innovation in their respective fields.
Conclusion
Deyu Kong is a dedicated inventor whose work on aminopyrimidine compounds represents a significant advancement in medical research. His contributions are paving the way for new therapeutic strategies in treating various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile